New and Generic Drug Approvals:

*ADVIL Cold & Sinus (ibuprofen and pseudoephedrine hydrochloride) Capsules, Wyeth Consumer Healthcare, Labeling Revision *APTIVUS (tipranavir) Capsules, Boehringer Ingelheim Pharmaceuticals, Inc., New or Modified Indication *APTIVUS (tipranavir) Oral Solution, Boehringer Ingelheim Pharmaceuticals, Inc., Approval *APTIVUS (tipranavir) Oral Solution, Boehringer Ingelheim Pharmaceuticals, Inc., Approval *Azithromycin Oral Suspension, Teva Pharmaceuticals USA, Approval *Celestone Soluspan (betamethasone acetate and betamethasone sodium phosphate) Injection, Schering Corp., Labeling Revision *DUREZOL (difluprednate) Ophthalmic Emulsion, Sirion Therapeutics, Inc., Approval *Famotidine Injection, Akorn-Strides, LLC, Approval *PRANDIMET (repaglinide and metformin hydrochloride) Tablets, Novo Nordisk, Inc., Approval *VIRAMUNE (nevirapine) Oral Suspension, Boehringer Ingelheim Pharmaceuticals, Inc., Patient Population Altered *VIRAMUNE (nevirapine) Tablet, Boehringer Ingelheim Pharmaceuticals, Inc., Patient Population Altered